Enough already.

This editorial argues, without reservation, that 36 Gy craniospinal irradiation (CSI) for so-called “high-risk” medulloblastoma should be retired—without further study—given the lack of proven interval benefit over lower dose CSI and the unacceptable long term sequelae with an accompanying article demonstrating “perhaps up to a quarter, and possibly less, of those children originally diagnosed with medulloblastoma were 15-year survivors and not disabled, yet still subject to hypertension, stroke, hearing loss, mental health disorders, or infertility.” | Fisher, J Clin Oncol 2023